Crossref
An ever-stronger case for circulating tumor DNA monitoring in ALK+ lung cancer
AME Clinical Trials Review · 2023
DOI: 10.21037/actr-23-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift AME Clinical Trials Review, 2023. Verfasst von Petros Christopoulos. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Christopoulos, P. (2023). An ever-stronger case for circulating tumor DNA monitoring in ALK+ lung cancer. AME Clinical Trials Review. https://doi.org/10.21037/actr-23-4
Vancouver
Christopoulos P. An ever-stronger case for circulating tumor DNA monitoring in ALK+ lung cancer. AME Clinical Trials Review. 2023. doi:10.21037/actr-23-4
BibTeX
@article{Christopoulos2023,
author = {Christopoulos, Petros},
title = {An ever-stronger case for circulating tumor DNA monitoring in ALK+ lung cancer},
journal = {AME Clinical Trials Review},
year = {2023},
doi = {10.21037/actr-23-4}
}
EUVIMED